Claritin-D Litigation Settlement Reached Between Schering, Andrx
This article was originally published in The Tan Sheet
Executive Summary
Litigation related to Impax Laboratories' generic version of Schering-Plough's Claritin-D OTC allergy drug is the last pending patent dispute involving the D formulation following a settlement with Andrx
You may also be interested in...
Dr. Reddy’s, Leiner Partnership Focusing On Switches
Dr. Reddy's Laboratories and Leiner Health Products are actively looking at potential Rx-to-OTC switch projects as they build on their partnership
Dr. Reddy’s, Leiner Partnership Focusing On Switches
Dr. Reddy's Laboratories and Leiner Health Products are actively looking at potential Rx-to-OTC switch projects as they build on their partnership
Dr. Reddy’s, Leiner Partnership Focusing On Switches
Dr. Reddy's Laboratories and Leiner Health Products are actively looking at potential Rx-to-OTC switch projects as they build on their partnership